Inquirer on MSN2d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
BioSpace3d
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
stocknews2d
3 Dividend Aristocrats With Consistent Payouts
Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...
PRODUCT OF THE YEAR USA UNVEILS 2025 AWARD WINNERS
USA, the nation's largest consumer-voted awards program dedicated to recognizing product innovation, has announced the ...
Badger Herald1d
Ketamine’s path to Medicaid coverage in Wisconsin marked by optimism, gathering acceptance
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
TheDerrick.com1d
Argentina says it will withdraw from the World Health Organization
A spokesman for President Javier Milei says he has ordered Argentina’s withdrawal from the World Health Organization due to profound differences with the U.N. agency. Milei’s action echoes that of ...